On the other hand, as compared to HER2 subtype of breast cancer, FAS and lipogenic enzyme levels have also been found to be reduced in TNBC while FAO appears to be enhanced and critically linked with MYC overexpression as seen from RNA-expression data from 771 breast cancer patients with primary human tumours [70]. This evidence concerns the gene ERBB2 and breast cancer.